• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

腹膜癌病：自然病史及腹腔内化疗的合理治疗干预措施

Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy.

作者信息

Sugarbaker P H

机构信息

Cancer Institute, Washington Hospital Center, DC 20010, USA.

出版信息

Cancer Treat Res. 1996;81:149-68. doi: 10.1007/978-1-4613-1245-1_13.

DOI:10.1007/978-1-4613-1245-1_13
PMID:8834582
Abstract

The rationale and the treatment strategies for peritoneal carcinomatosis have gained prominence over the last decade. Their definite contribution to the management of gastrointestinal cancer has been established. The significant contributions are summarized in Table 7.

摘要

在过去十年中，腹膜癌病的基本原理和治疗策略已受到广泛关注。它们对胃肠道癌治疗的明确贡献已得到证实。显著贡献总结于表7中。

相似文献

1
Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy.腹膜癌病：自然病史及腹腔内化疗的合理治疗干预措施
Cancer Treat Res. 1996;81:149-68. doi: 10.1007/978-1-4613-1245-1_13.
2
[Therapeutic innovations in the management of peritoneal carcinomatosis from digestive origin: cytoreductive surgery and intraperitoneal chemotherapy].[消化系统来源腹膜癌病管理中的治疗创新：细胞减灭术与腹腔内化疗]
Rev Med Interne. 2006 May;27(5):382-91. doi: 10.1016/j.revmed.2005.08.017. Epub 2005 Oct 5.
3
Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.腹腔内癌症化疗药物的药代动力学和药效学。
Clin Pharmacokinet. 2012 Apr 1;51(4):203-24. doi: 10.2165/11598890-000000000-00000.
4
[Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin].[胃肠道原发性腹膜癌患者的外科治疗]
Z Gastroenterol. 2006 Dec;44(12):1237-45. doi: 10.1055/s-2006-927156.
5
Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review.辅助性腹腔内化疗治疗有腹膜播散风险的胃癌：一项系统评价。
J Surg Oncol. 2017 Feb;115(2):192-201. doi: 10.1002/jso.24476. Epub 2016 Nov 23.
6
Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.349 例腹膜癌患者 832 次腹腔内高压气溶胶化疗（PIPAC）干预的多中心综合方法学和技术分析：一项国际调查研究。
Eur J Surg Oncol. 2018 Jul;44(7):991-996. doi: 10.1016/j.ejso.2018.02.014. Epub 2018 Feb 22.
7
Clinical Efficacy of Combination Intravenous and Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis.静脉联合腹腔化疗治疗胃癌伴腹膜转移的临床疗效
Curr Pharm Biotechnol. 2018;19(12):956-962. doi: 10.2174/1389201019666181114121145.
8
A case of disseminated carcinomatosis of the bone marrow originating from gastric cancer 3 years after intraperitoneal chemotherapy against peritoneal carcinomatosis.1例在针对腹膜癌病进行腹腔化疗3年后发生的、源自胃癌的骨髓播散性癌病。
World J Surg Oncol. 2016 Apr 14;14:107. doi: 10.1186/s12957-016-0851-3.
9
Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management.胃肠道恶性肿瘤所致腹膜癌病：自然病程及治疗新前景
Acta Chir Belg. 1994 Jul-Aug;94(4):191-7.
10
Mechanism and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to carbon particles.腹膜癌病的机制与治疗：碳颗粒结合丝裂霉素C的腹腔内化疗
Cancer Treat Res. 1996;81:185-92. doi: 10.1007/978-1-4613-1245-1_16.

引用本文的文献

1
Management and Outcomes of Urinary Tract Involvement in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A Retrospective Cohort Study.减瘤性手术联合热灌注腹腔化疗（CRS/HIPEC）中泌尿系统受累的管理及结局：一项回顾性队列研究
Medicina (Kaunas). 2025 Jul 23;61(8):1331. doi: 10.3390/medicina61081331.
2
Evaluating the Long-Term Impact of Cytoreductive Surgery for Gastric Cancer with Peritoneal Metastasis: Are We on the Right Path?评估减瘤手术对伴有腹膜转移的胃癌的长期影响：我们是否走在正确的道路上？
J Pers Med. 2025 Jul 10;15(7):300. doi: 10.3390/jpm15070300.
3
Safety of BromAc with Mitomycin C during hyperthermic intraperitoneal chemotherapy (HIPEC): a preclinical study.
丝裂霉素C联合溴己新在腹腔热灌注化疗（HIPEC）中的安全性：一项临床前研究。
Am J Cancer Res. 2025 Mar 15;15(3):1213-1223. doi: 10.62347/HQJH9945. eCollection 2025.
4
Predictive Factors for the Discontinuation of Pressurized Intraperitoneal Aerosol Chemotherapy: Enhancing Patient Selection to Improve Oncological Outcomes-A Single-Center Experience.腹腔内加压气雾剂化疗停药的预测因素：优化患者选择以改善肿瘤学结局——单中心经验
Cancers (Basel). 2025 Jan 15;17(2):265. doi: 10.3390/cancers17020265.
5
How to Implement Pressurized Intraperitoneal Aerosol Chemotherapy into a National Health System Scenario: A Single-Center Retrospective Analysis of Costs and Economic Sustainability at a High-Volume Italian Hospital.如何在国家卫生系统的背景下实施腹腔内加压雾化化疗：意大利一家大型医院的单中心成本与经济可持续性回顾性分析
Cancers (Basel). 2024 Jul 24;16(15):2637. doi: 10.3390/cancers16152637.
6
Peritoneal Metastases from Extraperitoneal Primary Tumors: Incidence, Treatment, and Survival from a Nationwide Database.来自腹膜外原发性肿瘤的腹膜转移：基于全国性数据库的发病率、治疗及生存情况
Indian J Surg Oncol. 2023 Jun;14(Suppl 1):60-66. doi: 10.1007/s13193-022-01592-w. Epub 2022 Jul 20.
7
Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study.阑尾癌伴腹膜转移中淋巴结转移是否重要？美国 HIPEC 协作研究。
J Gastrointest Surg. 2022 Dec;26(12):2569-2578. doi: 10.1007/s11605-022-05489-5. Epub 2022 Oct 18.
8
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials.结直肠癌腹膜转移的细胞减灭术及腹腔内热灌注化疗：关键临床试验综述
J Clin Med. 2022 Jun 14;11(12):3406. doi: 10.3390/jcm11123406.
9
Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases.腹膜转移患者腹腔内热灌注化疗（PIPAC）治疗的选择标准
Cancers (Basel). 2022 May 23;14(10):2557. doi: 10.3390/cancers14102557.
10
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).微卫星状态和 RAS/RAF 基因突变状态作为细胞减灭术和腹腔热灌注化疗（HIPEC）治疗结直肠腹膜转移的预后因素。
Ann Surg Oncol. 2022 Jun;29(6):3405-3417. doi: 10.1245/s10434-021-11045-3. Epub 2021 Nov 16.